Where many therapeutic compounds are raised in bacteria or fungi, plants sometimes offer many advantages as bioreactors. The problem tends to be standardization, and conditions that ensure that the desired proteins are produced This episode features Jim Wilson from Zea Biologics, where cleanrooms, precise regulation of all aspects of plant growth, and massive data collection allow for the production of biologics that treat everything from hemophilia to influenza. Using precision "pharming" drugs and be produced at a lower cost in less time, and the products tend to be stable at room temperature, allowing wider distribution at lower cost, with a lower carbon footprint. www.zeabio.com